Unless you’ve been living under a rock- we’re in a global pandemic. By now, you’ve probably had the pleasure of having your brain tickled through your nose via nasal swab, fretting that your annual winter cold is actually the plague. Whilst most of us can handle the violation that is a nasal swab, testing children
Read More
Fresh off a major marketing campaign which saw their branding projected into millions of Aussie households as broadcast partners of the Tokyo 2020 Olympic Games, neo-lender Wisr (ASX: WZR) have reported 280% revenue growth to be eyeing profitability for the first time in their short history. Emerging as the non-bank lender of choice amongst the
Read More
With well over a year of working from home under our belts it’s safe to say that hybrid and remote work is no longer a temporary solution. Our new way of working has spurred the growth of some organisations providing solutions to enhance the digital working experience. LiveTiles (ASX: LVT) is one such company, creating
Read More
Following the $39 billion takeover from global payments company Square, early stage investors of Afterpay (ASX: APT) will be pleased the deal was done prior to the release of their FY21 results which show the handbrake has been pulled on growth in the BNPL market. While the percentage figures at the top of their results
Read More
Further consolidating their position as the largest operator of regional veterinary clinics, Apiam Animal Health (ASX: AHX) is continuing its acquisition spree with Harbour City Veterinary Surgery the latest to join their network at a time when pet ownership has soared. The clinic is located in Gladstone, Queensland, which is a rapidly growing town south-east
Read More
The complex nature of cancer means that scientists are having to get creative to improve diagnosis and treatment. Experts in the field of oncology ‘theranostics’ (combined therapeutic and diagnostic solutions), Clarity Pharmaceuticals (ASX: CU6) is due to make it’s ASX debut today. Clarity has raised $92 million at $1.40 per share. Upon listing their indicative
Read More
With COVID dominating headlines for well over a year, you may not have noticed the worsening opioid crisis. Specifically in the United States where there has been a steep rise in overdose related deaths in the past 12 months. Data released by the National Centre for Health Statistics in July showed that in the year
Read More
Riding the tailwinds of the pandemic which has led to a fundamental shift in family planning and wellness, fertility experts Monash IVF (ASX: MVF) have reported a raft of new business for their reproductive services which resulted in a 117% increase in profit as demand for IVF has surged. Reporting their FY21 results, Monash IVF
Read More
Think of VEEM Marine (ASX: VEE) as the team doing their best behind the scenes to make your experience better when lockdown ends and you finally board your yacht. Picture yourself: mimosa in hand, out on the ocean, enjoying the sun. Keeping that mimosa firmly in your hand and not spilled all over the deck
Read More
The old school broker model is fading with online access to investors enabling public companies to reach more investors instantly. This concept of digital capital raises from sophisticated investors has been dominated by Fresh Equities since 2017 but keen for a slice of the action, media company Aspermont (ASX: ASP) has declared intentions to enter
Read More
